Mechanism of 3 mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP)

M. Jomain Baum, Vern L. Schramm, R. W. Hanson

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

The hypoglycemic agent 3 mercaptopicolinic acid inhibits gluconegenesis from lactate by isolated, perfused livers from fasted rats and guinea pigs. A 3 mercaptopicolinate concentration of 50 μm caused a sharp decrease in glucose synthesis, with virtually complete inhibition at 100 μm. This inhibitory effect was reversed completely when 3 mercaptopicolinate was removed and the rate of glucose synthesis returned to normal values within 2 min. Oxygen cnsumption was not altered, even at the highest concentration of inhibitor. Gluconeogenesis from glycerol by guinea pig liver was blocked completely by 100 μm 3 mercaptopicolinate but was inhibited only partially in rat liver. After removal of the inhibitor glucose synthesis returned to levels higher than noted before the addition of this compound. The formation of P enolpyruvate by isolated guinea pig liver mitochondria metabolizing α ketoglutarate (State 3) was inhibited markedly by 3 mercaptopicolinate, but malate conversion to P enolpyruvate was considerably less sensitive to inhibition. Kinetic studies with purified P enolpyruvate carboxykinase from rat liver cytosol indicate that 3 mercaptopicolinate is a noncompetitive inhibitor with respect to both oxalacetate and MnGTP2-, and that simultaneous saturation with both substrates does not diminish this inhibition. The inhibitory effects of 3 mercaptopicolinate occur primarily by decreasing the rate of product formation while having relatively minor effects on the apparent Michaelis constants for substrates. Inhibition constants for slope and intercept effects ranged from 2 to 9 μm 3 mercaptopicolinate, and the inhibition patterns were dependent on the concentration of free Mn2+ present. Comparison of the inhibition constant with the observed inhibition of gluconeogenesis in livers perfused with 3 mercaptopicolinate supports the contention that P enolpyruvate carboxykinase is the site of action of this inhibitor. The possibility that 3 mercaptopicolinate inhibition occurs by binding either free or bound manganese was eliminated by determination of the dissociation constant of 0.51 mM for the manganese 3 mercaptopicolinate complex. In addition, no tightly bound, slowly exchanging metal was bound to purified enzyme protein. These results suggest that 3 mercaptopicolinate inhibits by the removal of a tightly bound, rapidly exchanging metal ion other than Mn2+.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalJournal of Biological Chemistry
Volume251
Issue number1
StatePublished - 1976
Externally publishedYes

Fingerprint

Phosphoenolpyruvate Carboxykinase (GTP)
Liver
Rats
Guinea Pigs
Gluconeogenesis
Manganese
Glucose
3-mercaptopicolinic acid
Metals
Mitochondria
Liver Mitochondrion
Substrates

ASJC Scopus subject areas

  • Biochemistry

Cite this

Mechanism of 3 mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP). / Jomain Baum, M.; Schramm, Vern L.; Hanson, R. W.

In: Journal of Biological Chemistry, Vol. 251, No. 1, 1976, p. 37-44.

Research output: Contribution to journalArticle

@article{8380124207db44cb80f090486aff86e1,
title = "Mechanism of 3 mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP)",
abstract = "The hypoglycemic agent 3 mercaptopicolinic acid inhibits gluconegenesis from lactate by isolated, perfused livers from fasted rats and guinea pigs. A 3 mercaptopicolinate concentration of 50 μm caused a sharp decrease in glucose synthesis, with virtually complete inhibition at 100 μm. This inhibitory effect was reversed completely when 3 mercaptopicolinate was removed and the rate of glucose synthesis returned to normal values within 2 min. Oxygen cnsumption was not altered, even at the highest concentration of inhibitor. Gluconeogenesis from glycerol by guinea pig liver was blocked completely by 100 μm 3 mercaptopicolinate but was inhibited only partially in rat liver. After removal of the inhibitor glucose synthesis returned to levels higher than noted before the addition of this compound. The formation of P enolpyruvate by isolated guinea pig liver mitochondria metabolizing α ketoglutarate (State 3) was inhibited markedly by 3 mercaptopicolinate, but malate conversion to P enolpyruvate was considerably less sensitive to inhibition. Kinetic studies with purified P enolpyruvate carboxykinase from rat liver cytosol indicate that 3 mercaptopicolinate is a noncompetitive inhibitor with respect to both oxalacetate and MnGTP2-, and that simultaneous saturation with both substrates does not diminish this inhibition. The inhibitory effects of 3 mercaptopicolinate occur primarily by decreasing the rate of product formation while having relatively minor effects on the apparent Michaelis constants for substrates. Inhibition constants for slope and intercept effects ranged from 2 to 9 μm 3 mercaptopicolinate, and the inhibition patterns were dependent on the concentration of free Mn2+ present. Comparison of the inhibition constant with the observed inhibition of gluconeogenesis in livers perfused with 3 mercaptopicolinate supports the contention that P enolpyruvate carboxykinase is the site of action of this inhibitor. The possibility that 3 mercaptopicolinate inhibition occurs by binding either free or bound manganese was eliminated by determination of the dissociation constant of 0.51 mM for the manganese 3 mercaptopicolinate complex. In addition, no tightly bound, slowly exchanging metal was bound to purified enzyme protein. These results suggest that 3 mercaptopicolinate inhibits by the removal of a tightly bound, rapidly exchanging metal ion other than Mn2+.",
author = "{Jomain Baum}, M. and Schramm, {Vern L.} and Hanson, {R. W.}",
year = "1976",
language = "English (US)",
volume = "251",
pages = "37--44",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Mechanism of 3 mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP)

AU - Jomain Baum, M.

AU - Schramm, Vern L.

AU - Hanson, R. W.

PY - 1976

Y1 - 1976

N2 - The hypoglycemic agent 3 mercaptopicolinic acid inhibits gluconegenesis from lactate by isolated, perfused livers from fasted rats and guinea pigs. A 3 mercaptopicolinate concentration of 50 μm caused a sharp decrease in glucose synthesis, with virtually complete inhibition at 100 μm. This inhibitory effect was reversed completely when 3 mercaptopicolinate was removed and the rate of glucose synthesis returned to normal values within 2 min. Oxygen cnsumption was not altered, even at the highest concentration of inhibitor. Gluconeogenesis from glycerol by guinea pig liver was blocked completely by 100 μm 3 mercaptopicolinate but was inhibited only partially in rat liver. After removal of the inhibitor glucose synthesis returned to levels higher than noted before the addition of this compound. The formation of P enolpyruvate by isolated guinea pig liver mitochondria metabolizing α ketoglutarate (State 3) was inhibited markedly by 3 mercaptopicolinate, but malate conversion to P enolpyruvate was considerably less sensitive to inhibition. Kinetic studies with purified P enolpyruvate carboxykinase from rat liver cytosol indicate that 3 mercaptopicolinate is a noncompetitive inhibitor with respect to both oxalacetate and MnGTP2-, and that simultaneous saturation with both substrates does not diminish this inhibition. The inhibitory effects of 3 mercaptopicolinate occur primarily by decreasing the rate of product formation while having relatively minor effects on the apparent Michaelis constants for substrates. Inhibition constants for slope and intercept effects ranged from 2 to 9 μm 3 mercaptopicolinate, and the inhibition patterns were dependent on the concentration of free Mn2+ present. Comparison of the inhibition constant with the observed inhibition of gluconeogenesis in livers perfused with 3 mercaptopicolinate supports the contention that P enolpyruvate carboxykinase is the site of action of this inhibitor. The possibility that 3 mercaptopicolinate inhibition occurs by binding either free or bound manganese was eliminated by determination of the dissociation constant of 0.51 mM for the manganese 3 mercaptopicolinate complex. In addition, no tightly bound, slowly exchanging metal was bound to purified enzyme protein. These results suggest that 3 mercaptopicolinate inhibits by the removal of a tightly bound, rapidly exchanging metal ion other than Mn2+.

AB - The hypoglycemic agent 3 mercaptopicolinic acid inhibits gluconegenesis from lactate by isolated, perfused livers from fasted rats and guinea pigs. A 3 mercaptopicolinate concentration of 50 μm caused a sharp decrease in glucose synthesis, with virtually complete inhibition at 100 μm. This inhibitory effect was reversed completely when 3 mercaptopicolinate was removed and the rate of glucose synthesis returned to normal values within 2 min. Oxygen cnsumption was not altered, even at the highest concentration of inhibitor. Gluconeogenesis from glycerol by guinea pig liver was blocked completely by 100 μm 3 mercaptopicolinate but was inhibited only partially in rat liver. After removal of the inhibitor glucose synthesis returned to levels higher than noted before the addition of this compound. The formation of P enolpyruvate by isolated guinea pig liver mitochondria metabolizing α ketoglutarate (State 3) was inhibited markedly by 3 mercaptopicolinate, but malate conversion to P enolpyruvate was considerably less sensitive to inhibition. Kinetic studies with purified P enolpyruvate carboxykinase from rat liver cytosol indicate that 3 mercaptopicolinate is a noncompetitive inhibitor with respect to both oxalacetate and MnGTP2-, and that simultaneous saturation with both substrates does not diminish this inhibition. The inhibitory effects of 3 mercaptopicolinate occur primarily by decreasing the rate of product formation while having relatively minor effects on the apparent Michaelis constants for substrates. Inhibition constants for slope and intercept effects ranged from 2 to 9 μm 3 mercaptopicolinate, and the inhibition patterns were dependent on the concentration of free Mn2+ present. Comparison of the inhibition constant with the observed inhibition of gluconeogenesis in livers perfused with 3 mercaptopicolinate supports the contention that P enolpyruvate carboxykinase is the site of action of this inhibitor. The possibility that 3 mercaptopicolinate inhibition occurs by binding either free or bound manganese was eliminated by determination of the dissociation constant of 0.51 mM for the manganese 3 mercaptopicolinate complex. In addition, no tightly bound, slowly exchanging metal was bound to purified enzyme protein. These results suggest that 3 mercaptopicolinate inhibits by the removal of a tightly bound, rapidly exchanging metal ion other than Mn2+.

UR - http://www.scopus.com/inward/record.url?scp=0017284425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017284425&partnerID=8YFLogxK

M3 - Article

VL - 251

SP - 37

EP - 44

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -